Bioavailability: Injections have very high bioavailability (around 89%), meaning most of the drug enters the bloodstream
A multicenter, randomized, placebo-controlled pilot trial was done to determine the safety and effectiveness of 40 or 80 mg dosages of SOD in patients with progressive idiopathic interstitial pneumonias
These therapies often come with premium pricing due to complex manufacturing processes, patent protections, and high R&D investments, making them inaccessible for many patients without robust insurance coverage
All glucagon-like peptide-1 receptor agonists (GLP-1 RAs) licensed for type 2 diabetes mellitus (T2DM) are facing a national shortage, the government has said
Overlapping two GLP-1 class drugs produces additive GI side effects that can be severe enough to require medical attention
AOD 9604 is available for research and laboratory purposes only